Literature DB >> 12454131

Reliability of nested PCR for detection of Chlamydia pneumoniae DNA in atheromas: results from a multicenter study applying standardized protocols.

Petra Apfalter1, Ojan Assadian, Francesco Blasi, Jens Boman, Charlotte A Gaydos, Michael Kundi, Athanasios Makristathis, Marion Nehr, Manfred L Rotter, Alexander M Hirschl.   

Abstract

The present multicenter study was designed to find explanations for the discrepancies in the reported rates of detection of Chlamydia pneumoniae DNA in endarterectomy specimens. Coded identical sets of (i) a C. pneumoniae DNA dilution series (panel 1; n = 10), (ii) spiked control tissue specimens (panel 2; n = 10 specimens, including 5 negative controls), and (iii) endarterectomy specimens (panel 3; 15 atheromas, 5 negative controls) were analyzed at four laboratories by three standardized DNA extraction methods in each laboratory and a nested touchdown PCR protocol targeting the ompA gene of C. pneumoniae. Panel 1 samples were correctly identified as positive to levels of 0.3 inclusion-forming units (IFU)/PCR mixture (100%) and 0.03 IFU/PCR mixture (50%). All negative controls were correctly reported as negative. Panel 2 samples were identified as C. pneumoniae positive to levels of 0.01 IFU/PCR mixture (100%) and 0.005 IFU/PCR mixture (91%), independent of the DNA extraction method used, and only one false-positive result was reported. For panel 3 samples, 5 of 240 (2%) analyses (in which DNA extractions and PCR were performed at the same laboratory) were positive; the positive specimens were from three endarterectomy specimens and two negative controls. After exchange of DNA extracts between laboratories, 13 of 15 atheroma samples were C. pneumoniae DNA positive in at least 1 of a series of 48 analyses per atheroma sample; however, the overall positivity rate did not exceed 5% (33 of 720 analyses) and therefore was lower than that for the negative controls (8%; 19 of 240 analyses). Not a single positive result could be achieved when all panel 3 extracts (n = 240 analyses) were reamplified by a 16S rRNA PCR followed by hybridization with a C. pneumoniae-specific probe. Statistical analyses demonstrated that positive results did not occur in an independent and random fashion and could most likely be explained by amplicon carryover at the nested PCR level as well as amplicon introduction during DNA extraction, but not by the patterns of distribution of very low target levels or a certain DNA extraction protocol. The results of studies by nested PCR for detection of the prevalence of C. pneumoniae will always be questionable.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454131      PMCID: PMC154590          DOI: 10.1128/JCM.40.12.4428-4434.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens.

Authors:  P Apfalter; F Blasi; J Boman; C A Gaydos; M Kundi; M Maass; A Makristathis; A Meijer; R Nadrchal; K Persson; M L Rotter; C Y Tong; G Stanek; A M Hirschl
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease.

Authors:  C A Jantos; A Nesseler; W Waas; W Baumgärtner; H Tillmanns; W Haberbosch
Journal:  Clin Infect Dis       Date:  1999-05       Impact factor: 9.079

Review 3.  Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.

Authors:  J T Grayston
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

Review 4.  Chlamydia pneumoniae in atherosclerotic tissue.

Authors:  D Taylor-Robinson; B J Thomas
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

5.  High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors.

Authors:  J Boman; S Söderberg; J Forsberg; L S Birgander; A Allard; K Persson; E Jidell; U Kumlin; P Juto; A Waldenström; G Wadell
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

6.  Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque.

Authors:  M Thomas; Y Wong; D Thomas; M Ajaz; V Tsang; P J Gallagher; M E Ward
Journal:  Circulation       Date:  1999-06-01       Impact factor: 29.690

7.  Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease.

Authors:  Y K Wong; K D Dawkins; M E Ward
Journal:  J Am Coll Cardiol       Date:  1999-11-01       Impact factor: 24.094

8.  Chlamydia pneumoniae in abdominal aortic aneurysms: abundance of membrane components in the absence of heat shock protein 60 and DNA.

Authors:  A Meijer; J A van Der Vliet; P J Roholl; S K Gielis-Proper; A de Vries; J M Ossewaarde
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-11       Impact factor: 8.311

9.  Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection.

Authors:  F Blasi; J Boman; G Esposito; G Melissano; R Chiesa; R Cosentini; P Tarsia; Y Tshomba; M Betti; M Alessi; N Morelli; L Allegra
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

10.  Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease.

Authors:  M Maass; C Bartels; P M Engel; U Mamat; H H Sievers
Journal:  J Am Coll Cardiol       Date:  1998-03-15       Impact factor: 24.094

View more
  18 in total

1.  Comments on the failure to detect Chlamydia pneumoniae in atherosclerosis.

Authors:  D Taylor-Robinson; J Boman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-23       Impact factor: 3.267

Review 2.  Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?

Authors:  Kensuke Shima; Gregor Kuhlenbäumer; Jan Rupp
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

Review 3.  In-house nucleic acid amplification assays in research: how much quality control is needed before one can rely upon the results?

Authors:  Petra Apfalter; Udo Reischl; Margaret R Hammerschlag
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 4.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  Two quality control exercises involving nucleic acid amplification methods for detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae and carried out 2 years apart (in 2002 and 2004).

Authors:  K Loens; T Beck; D Ursi; S Pattyn; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

6.  Fecal detection of enterotoxigenic Bacteroides fragilis.

Authors:  L A Chen; S Van Meerbeke; E Albesiano; A Goodwin; S Wu; H Yu; K Carroll; C Sears
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-15       Impact factor: 3.267

7.  Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.

Authors:  Carlo Contini; Silva Seraceni; Rosario Cultrera; Massimiliano Castellazzi; Enrico Granieri; Enrico Fainardi
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-21

8.  Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial.

Authors:  Hans F Berg; Boulos Maraha; Anneke van der Zee; Siska K Gielis; Paul J M Roholl; Gert-Jan Scheffer; Marcel F Peeters; Jan A J W Kluytmans
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

9.  Immunohistostaining assays for detection of Chlamydia pneumoniae in atherosclerotic arteries indicate cross-reactions with nonchlamydial plaque constituents.

Authors:  Vicky Y Hoymans; Johan M Bosmans; Dominique Ursi; Wim Martinet; Floris L Wuyts; Eric Van Marck; Martin Altwegg; Christiaan J Vrints; Margareta M Ieven
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

10.  An optimized nested polymerase chain reaction (PCR) approach allows detection and characterization of human immunodeficiency virus type 1 (HIV-1) env and gag genes from clinical samples.

Authors:  Dayse Locateli; Patricia H Stoco; Carlos R Zanetti; Aguinaldo R Pinto; Edmundo C Grisard
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.